IDEXX Laboratories Finance Chief Brian McKeon to Retire
Express News | IDEXX Laboratories Inc - Reaffirms 2024 Full Year Guidance
Express News | IDEXX Laboratories Inc: Brian Mckeon to Retire From IDEXX in June 2025
Express News | IDEXX Laboratories Inc - Brian Mckeon to Retire From IDEXX on June 1, 2025
IDEXX Announces CFO Transition
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet
Quality Cyclicals Are Expected to Continue Going Up, Here Are the Top-rated by Morgan Stanley
There's Reason For Concern Over IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Price
Oppenheimer: This momentum indicator indicates that the U.S. stock market's upward trend will continue into next year.
According to Oppenheimer's data, the Monthly Relative Strength Index (RSI) indicates that the overall US stock market will not peak until 2025.
This Momentum Indicator Says the S&P Won't Peak Until Next Year
Unusual Options Activity: CCK, CMG and Others Attract Market Bets, CCK V/OI Ratio Reaches 179.2
EST Nov 15th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
IDEXX Laboratories (NASDAQ:IDXX) Shareholders Have Earned a 10% CAGR Over the Last Five Years
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $475
Is IDEXX Laboratories (IDXX) The Best Pet Stock To Invest In According To Analysts?
Could The Market Be Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Its Attractive Financial Prospects?
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $435 to $500
Decoding 5 Analyst Evaluations For IDEXX Laboratories
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today
IDEXX Labs Is Maintained at Overweight by Barclays
IDEXX Laboratories Analyst Ratings